| 41.34 0.01 (0.02%) | 06-12 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 49.81 | 1-year : | 58.18 |
| Resists | First : | 42.65 | Second : | 49.81 |
| Pivot price | 40.65 |
|||
| Supports | First : | 39.31 | Second : | 37.25 |
| MAs | MA(5) : | 40.19 |
MA(20) : | 40.44  |
| MA(100) : | 38.01 |
MA(250) : | 36.25 |
|
| MACD | MACD : | 0.3 |
Signal : | 0.5 |
| %K %D | K(14,3) : | 60.2 |
D(3) : | 48.5 |
| RSI | RSI(14): 55.8 |
|||
| 52-week | High : | 42.65 | Low : | 29.62 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ FFTY ] has closed below upper band by 32.6%. Bollinger Bands are 22.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 42.07 - 42.23 | 42.23 - 42.42 |
| Low: | 40.43 - 40.6 | 40.6 - 40.8 |
| Close: | 41.02 - 41.3 | 41.3 - 41.62 |
The CapForce IBD 50 ETF is designed to mirror the performance outcomes of the IBD 50 Index. Developed by Investor's Business Daily as its signature investment vehicle, the IBD 50 provides access to U.S. large and mid-sized companies that display robust earnings growth alongside strong stock price appreciation. This fund implements a consistent, systematic methodology to pinpoint stocks that align with its established leadership standards.
Thu, 04 Jun 2026
Smart beta meets IBD: CapForce rebrands Innovator's IBD funds in rules-based push - MSN
Wed, 29 Apr 2026
Capital-FORCE Welcomes IBD® 50 (FFTY) and IBD® Breakout Opportunities (BOUT) ETFs to New Rules-Based ETF Platform - Business Wire
Fri, 17 Apr 2026
Shareholders approve reorganization of two Innovator ETFs - Investing.com
Fri, 17 Apr 2026
Capital-FORCE Enters ETF Market with Acquisition of Innovator IBD - Business Wire
Wed, 04 Mar 2026
S&P 500: We Told You So — These IBD 50 Stocks Dominate This Year - Investor's Business Daily
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
AMEX
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Asset Management
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|